Skip to main content
MAIA
NYSE Life Sciences

CEO Vlad Vitoc Buys 100,000 MAIA Shares for $100,000 on the Open Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.24
Mkt Cap
$77.188M
52W Low
$0.87
52W High
$3.19
52W Position info
43% above low
Off High info
61% below high
Rel. Volume info
3.6× avg
Market data snapshot near publication time

MAIA sits 43% above its 52-week low of $0.87 on elevated volume (3.6× avg).

Summary

CEO Vlad Vitoc bought 100,000 MAIA shares for $100,000 at $1.00 in two open-market trades on November 13 and 16, lifting his direct stake to 1,149,121 shares.


Key Events · Ownership and Investor Activity · MAIA

  • CEO Open-Market Purchase

    Vlad Vitoc bought 100,000 shares for $100,000 at $1.00 per share in two transactions: 60,400 shares on 2026-11-13 and 39,600 shares on 2026-11-16.

  • Stake Rises to 1.15M Shares

    Post-transaction direct holdings are 1,149,121 shares; an additional 210,100 shares are held indirectly by his spouse, of which he disclaims beneficial ownership.

  • Timing After Positive Updates

    The buying followed the 2026-11-09 10-Q, which showed the Q3 net loss narrowed to $7.18M from $8.90M, and the 2026-11-17 8-K reporting an 88% disease control rate in Phase 2 THIO-101 Part C.

  • Entry Price Below Market

    The $1.00 purchase price compares with today's $1.24 stock price; the second tranche was executed at a weighted average of $0.9905 to $1.0000.


Analysis · MAIA · Life Sciences

Why it matters: the CEO put $100,000 of his own money into MAIA at $1.00 a share, just days after the company reported narrowed Q3 losses and updated Phase 2 THIO-101 data showing an 88% disease control rate in third-line NSCLC. The sum is modest relative to the company's size, but it is a real open-market purchase rather than an option exercise, and it lands right after two positive disclosures. With the stock at today's $1.24, the shares have already moved above his $1.00 entry price.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MAIA was trading at $1.24 on NYSE in the Life Sciences sector, with a market capitalization of approximately $77.2M. The 52-week trading range was $0.87 to $3.19. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MAIA - Latest Insights

MAIA
Nov 17, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $1.29 info
Change: +$0.270 (+26%) info
Market Cap: $77.188M info
MAIA
Nov 09, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $1.29 info
Change: +$0.200 (+18%) info
Market Cap: $77.188M info